Number of isolates tested for extended-spectrum cephalosporins in Norway
Norway: Number of isolates tested for extended-spectrum cephalosporins was 126 in 2018. ▲ Rising
Number of isolates tested for extended-spectrum cephalosporins in Norway, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for number of isolates tested for extended-spectrum cephalosporins in Norway is 126, measured in 2018. That is the highest value across all 10 years on record.
The figure is up 17.8% on the previous year and up 14.5% over ten years.
Over the whole period, number of isolates tested for extended-spectrum cephalosporins in Norway peaked at 126 in 2018 and was at its lowest, 46, in 2010.
Norway ranks 27th of 51 countries on this measure, in the middle of the range.
Number of isolates tested for extended-spectrum cephalosporins in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 110 | — |
| 2010 | 46 | -58.2% |
| 2011 | 77 | +67.4% |
| 2012 | 110 | +42.9% |
| 2013 | 112 | +1.8% |
| 2014 | 110 | -1.8% |
| 2015 | 110 | +0.0% |
| 2016 | 111 | +0.9% |
| 2017 | 107 | -3.6% |
| 2018 | 126 | +17.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 110 | 110 | 110 | 1 |
| 2010s | 101 | 46 | 126 | 9 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0257 units per person (2025)
- Population ages 05-09, male, annual growth rate -1.36 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0273 units per person (2025)
- Population ages 10-14, female, annual growth rate -1.37 % change on previous year (2025)
Frequently asked questions
- What is number of isolates tested for extended-spectrum cephalosporins in Norway?
- Number of isolates tested for extended-spectrum cephalosporins in Norway was 126 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest number of isolates tested for extended-spectrum cephalosporins recorded in Norway?
- The highest recorded value was 126 in 2018.
- What is the lowest number of isolates tested for extended-spectrum cephalosporins recorded in Norway?
- The lowest recorded value was 46 in 2010.
- How does Norway rank for number of isolates tested for extended-spectrum cephalosporins?
- Norway ranks 27th out of 51 countries with data for 2018.
- Is number of isolates tested for extended-spectrum cephalosporins rising or falling in Norway?
- Over the last ten years it is up 14.5%. The long-run trend across the full record is rising.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Number of isolates tested for extended-spectrum cephalosporins. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).